Docetaxel

AUG 18, 2026 · PHASE 3 TRIAL

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 3 trial registry record with no reported results; enrollment is complete but outcome data are not yet posted, making it a planned or ongoing study only.

AUG 13, 2026 · PHASE 3 TRIAL

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

ClinicalTrials.gov

This is a Phase 3 trial registration with no posted results; the study is active but not recruiting, and efficacy and safety outcomes have not yet been reported.

AUG 11, 2026 · PHASE 3 TRIAL

Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

ClinicalTrials.gov

This is a clinical trial registry record describing a planned or ongoing Phase 3 study with no results posted; efficacy and safety data are not yet available in this source.

AUG 4, 2026 · PHASE 2 TRIAL

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

ClinicalTrials.gov

This is an active Phase 2 trial registration with no results posted; the study design and rationale are described but no efficacy or safety outcomes are reported.